Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 2CRSI S.A AL2SI Apr 24, 2025 3.90 +3.17   
 74Software 74SW Apr 24, 2025 30.50 +0.66   
 Ab Science AB Apr 24, 2025 1.47 +3.37   
 ABC Arbitrage ABCA Apr 24, 2025 5.96 +0.34   
 ABEO SA ABEO Apr 24, 2025 9.40 -0.63   
 Abionyx Pharma ABNX Apr 24, 2025 1.21 -1.31   
 Abivax ABVX Apr 24, 2025 6.12 +1.32   
 Acanthe Developpement SA ACAN Apr 24, 2025 0.32 +1.06   
 Accor SA AC Apr 24, 2025 40.66 +0.15   
 Acheter-Louer.FR ALALO Apr 24, 2025 0.00 +25.00   
 Acteos EOS Apr 24, 2025 1.03 -3.67   
 Actia Group ALATI Apr 24, 2025 2.90 +1.40   
 Activium Group MLACT Apr 24, 2025 1.22 0.00   
 Adeunis ALARF Apr 24, 2025 0.60 +10.00   
 Adocia ADOC Apr 24, 2025 3.88 -2.76   
 Adomos ALADO Apr 24, 2025 0.08 -3.20   
 Adux ALDUX Apr 24, 2025 1.62 -0.92   
 Advicenne ALDVI Apr 24, 2025 1.71 -1.72   
 Advini ALAVI Apr 24, 2025 13.20 +0.38   
 Aelis Farma S.A. AELIS Apr 24, 2025 1.19 +2.15   
 Aerkomm Inc AKOM Apr 24, 2025 2.80 0.00   
 Aeroports de Paris SA ADP Apr 24, 2025 107.00 +1.71   
 Affluent Medical AFME Apr 24, 2025 1.35 -1.46   
 Afyren ALAFY Apr 24, 2025 1.68 +0.60   
 Agripower France SA ALAGP Apr 24, 2025 0.95 0.00   
 AgroGeneration ALAGR Apr 24, 2025 0.06 -4.29   
 Air France-KLM AF Apr 24, 2025 7.59 -1.30   
 Air Liquide AI Apr 24, 2025 178.58 +2.22   
 Airbus SE AIR Apr 24, 2025 137.26 -1.14   
 Akwel AKW Apr 24, 2025 7.46 -1.58   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.